Ontario, Canada, December 3rd, 2018 – Kensana Health is pleased to announce that its subsidiary Phytogro Canada has sponsored a $1-Million research chair at the University of Guelph. The Phytogro chair in Medicinal Phyto Substances will support development of new medicines from plants, including those made from cannabis. These products are intended to treat symptoms of illnesses and conditions, including cancer, epilepsy, insomnia, multiple sclerosis and post-traumatic stress disorder.

“We see U of G’s leading-edge researchers as key partners in achieving our goals to market novel pharmaceuticals derived from plants,” said PhytoGro CEO Ken Clement. “The only way for a plant to be utilized consistently as medicine is for it to be grown in a standardized way, batch after batch. U of G plant scientists have the expertise to achieve that consistency, and we are hoping to gain from their expertise.”

The new research chair will support an interdisciplinary, advanced horticultural production program. It will train graduate and undergraduate students to become future industry leaders and support the university’s Controlled Environment Systems Research Facility (CESRF), where world leading research and development in plant cultivation is well-established.